Clinical Trials List
Protocol NumberHCC
Active
2022-09-01 - 2026-08-31
Others
Recruiting2
-
Trial Applicant
-
Sponsor
-
Trial scale
Taiwan Multiple Center
-
Update
2026/02/01
Investigators and Locations
Principal Investigator
Co-Principal Investigator
- 何孟興 Division of General Surgery
- 林群書 Division of Radiation Therapy
- 洪志杰 Division of General Surgery
- 陳佳宏 Division of Hematology & Oncology
- 馮安捷 Division of General Surgery
- 楊志偉 Digestive System Department
- 謝宗保 Division of General Surgery
- 何幸豪 Division of Radiology
- 林榮鈞 Digestive System Department
- 張平穎 Division of Hematology & Oncology
- Chang-Ming Chern Division of Radiation Therapy
- 黃文彥 Division of Radiation Therapy
- 詹德全 Division of General Surgery
- 羅承翔 Division of Radiation Therapy
- 何景良 Division of Hematology & Oncology
- 林煊淮 Digestive System Department
- 張維洲 Division of Radiology
- 陳宣位 Digestive System Department
- 黃瑋琛 Digestive System Department
- 樊修龍 Division of General Surgery
- 蘇瑜富 Division of Radiation Therapy
- 沈伯鍵 Division of Radiation Therapy
- 施宇隆 Digestive System Department
- 張肇丰 Digestive System Department
- 陳登偉 Division of General Surgery
- 楊仁富 Division of Radiation Therapy
- 賴學緯 Division of Hematology & Oncology
- 陳保中 Digestive System Department
The Actual Total Number of Participants Enrolled
0 Recruiting
Principal Investigator
Co-Principal Investigator
- YU-YUN SHAO Division of Hematology & Oncology
- Chiun Hsu Division of Hematology & Oncology
- 楊宏志 Digestive System Department
- 蘇東弘 Digestive System Department
- 呂理駿 Division of Hematology & Oncology
- Shih-Jer Hsu Digestive System Department
- Chien-Hung Chen Digestive System Department
- TSUNG-HAO LIU Division of Hematology & Oncology
- Ying-Chun Shen Division of Hematology & Oncology
- Jia-Horng Kao Digestive System Department
- 曾岱宗 Digestive System Department
- Chun-Jen Liu Digestive System Department
- 林宗哲 Division of Hematology & Oncology
- JA-DER LIANG Digestive System Department
- KAI-WEN HUANG Division of General Surgery
- 蔡巧琳 Division of Radiation Therapy
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
27 participants
-
Global
0 participants